Ono Pharma USA Inc clinical trials

A country office of Ono Pharmaceutical Co. Ltd

The registry lists 21 studies whose lead sponsor is Ono Pharma USA Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 28, 2023.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. All Ono Pharmaceutical Co. Ltd studies →

• Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive DisorderCompletedNCT00514865Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT01844180Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)TerminatedNCT01887002Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced ThrombocytopeniaTerminatedNCT01345214Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Placebo and Active Controlled Study of ONO-6950 in Asthmatic PatientsCompletedNCT01536041Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple SclerosisCompletedNCT01081782Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic ImpairmentCompletedNCT01790607Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle GlaucomaCompletedNCT01670266Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• ONO-2952 Single-dose PET Study in Healthy Adult SubjectsCompletedNCT01613703Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With AsthmaCompletedNCT01551147Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• Controlled Study of ONO-1101 in Patients With Postoperative Tachyarrhythmias in JapanCompletedNCT00212680Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes MellitusCompletedNCT00212641Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic StrokeTerminatedNCT00046761Phase 2/3

  Sponsor listed in the registry: Ono Pharma USA Inc

• Multiple-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedNCT01489345Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult SubjectsCompletedNCT01297582Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Single Dose Escalation Study of ONO-9054 in Healthy VolunteersCompletedNCT01508988Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult SubjectsCompletedNCT01405651Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Pilot Study of ONO-5129 in Patients With Type 2 Diabetes MellitusCompletedNCT00335712Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ONO-2952 in Healthy Adult SubjectsCompletedNCT01364441Phase 1

  Sponsor listed in the registry: Ono Pharma USA Inc

• Effects of ONO-2506PO in Patients With Alzheimer's DiseaseCompletedNCT00083421Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc

• Controlled Study of ONO-5334 in Postmenopausal Women With Osteopenia or OsteoporosisCompletedNCT00532337Phase 2

  Sponsor listed in the registry: Ono Pharma USA Inc